Category Archives: Government/Research

Generation Alpha’s Trending Trauma

Speaker presenting to attentive diverse audience about online safety and 'Blackout Challenge' risks and prevention

In February 2026, nine-year-old JackLynn Blackwell died in her Stephenville, Texas backyard with a cord around her neck after seeing the “blackout challenge” online. A repackaging of the “choking game” that was first catalogued by the CDC in 2008, the blackout challenge is causing yourself to pass out. (This, in turn, causes “permanent, irreversible brain damage”.) It exploded on TikTok in 2021, as the For You algorithm began pushing self-strangulation videos to young users chasing a brief euphoric high from cerebral hypoxia. The trend has shown its lasting power: In South Orange Middle School in New Jersey, two students passed out after engaging in the challenge in 2024.

The blackout challenge has been noticed by politicians: on October 8, 2024, a bipartisan coalition of 14 attorney generals filed separate enforcement actions. “TikTok claims that their platform is safe for young people … [but] young people have died or gotten injured doing dangerous TikTok challenges,” remarked the group’s co-leader Letitia James (NY). In a March 23, 2026 press release, Congressman Jimmy Patronis (FL) stated, “As a parent, I cannot ignore the very real danger [the blackout challenge] poses to our children. Too many families have already suffered unimaginable loss.”  

Beyond concern, this childhood “thrill-seeking” has prompted some schools to take action. In New York, New Jersey and other states, schools have issued parental advisories in an attempt to protect children’s developmentally immature brains. One can hope that this trend is waning in popularity, and will soon be remembered only as an unfortunate episode in Generation Alpha’s past.

GLP-1 Drugs Surprising Neuroprotective Qualities

Diagram of GLP-1 (7-36) amide peptide showing amino acid sequence, side chains, chemical formulas, and α-helix structure

The weight-loss drug semaglutide, sold under the names Ozempic and Wegovy, may do far more than shrink waistlines. Research suggests it could also shield the brain after traumatic injury.

A 2026 study published in Neural Regeneration Research by scientists at Beijing Tiantan Hospital, and available in the PubMed database, found that semaglutide reduced brain swelling, preserved the blood-brain barrier, and blocked dangerous inflammatory cascades in mice with traumatic brain injuries. “Our findings reveal the dual anti-inflammatory and neuroprotective roles of semaglutide, providing important preclinical evidence for its clinical application in the acute phase of traumatic brain injury,” the researchers wrote.

The possibilities are enormous. Last year, a University of Wisconsin–Madison retrospective study of more than two million stroke patients found that those taking semaglutide had a mortality rate of just 5.26%, compared with 21.61% for non-users.

While human clinical trials for TBI are still needed, scientists say GLP-1 drugs represent the most promising new avenue for brain injury treatment in decades.

Study Bolsters Push for Personalized Treatment

Poster with the text 'Every Brain Injury is Different' overlaid on abstract neural network graphics

A study published in the journal Neurology (epub April 3, 2026; print April 28, 2026), and currently available through the NLM PubMed database, reveals evidence that traumatic brain injuries affect each person’s brain in remarkably unique ways. While such a scientific revelation may seem evident to survivors, it challenges one-size-fits-all treatment approaches.

Researchers led by Jake Mitchell of Monash University (Australia) analyzed brain scans from 407 TBI patients and 224 healthy controls using normative modeling, a technique that measures individual brains against healthy population norms much like pediatric growth charts.  Co -authored by researchers at the VA Palo Alto Healthcare System, the study found that no more than 23% of patients shared an extreme deviation in the same brain region.

The findings help explain why nearly 30 clinical trials for acute TBI treatments have failed to identify effective therapies. The study results also bolster the case for personalized brain injury medicine. 

Mississippi Joins States for Psychedelic Experimentation

A neon-lit chemical molecular structure floating in a colorful cosmic nebula with stars and galaxies.

Mississippi is now following Texas and a handful of other states, by positioning itself on the frontier of a potential neurological revolution. On March 19, 2026, Mississippi Governor Tate Reeves made history by signing HB 314 into law, authorizing the Mississippi State Department of Health to use $5 million of Mississippi’s opioid settlement money to fund clinical trials for the drug ibogaine. The bill takes effect July 1 and allows Mississippi to coordinate trials with other states, including Texas, which has already committed to its own program.

A psychoactive substance derived from the root of a plant native to Africa, ibogaine has been used for centuries in spiritual and healing ceremonies. More recently, it has gained scientific interest for its potential to treat opioid and cocaine addiction. Research suggests it increases signaling of important brain molecules linked to drug addiction and depression. Currently a Schedule I controlled substance, Americans seeking treatment must travel abroad at costs that reportedly reach up to $50,000 per session.

As stated by Dr. Nolan Williams, who was involved in the landmark 2024 Stanford University study that brought attention to the use of ibogaine for brain injury, “no other drug has ever been able to alleviate the functional and neuropsychiatric symptoms of traumatic brain injury.”

Brain Booster in Easter Basket & Candy Aisle Year-round

Wicker basket filled with chocolate peanut butter cups and colorful pastel candy eggs.

This Easter, as you unwrap a peanut butter egg, you may be doing your mind a bigger favor than you realize.

Peanut butter is a quiet powerhouse for cognitive health, loaded with niacin (B3) and vitamin E. Though peanuts may be in the legume family, rather than a nut, its brain benefits fall in line with them. A recent and compelling study, published in November 2025 by Clinical Nutrition, and accessible through PubMed, is a randomized crossover trial that gave 31 healthy older adults 60g/day of skin-roasted peanuts for 16 weeks. Using MRI scans as a guide, the authors concluded: “Daily consumption of skin-roasted peanuts for 16 weeks improved brain vascular function in healthy older men and women. These favorable effects may underlie the observed improvements in verbal memory.”

Dark chocolate truffle with a bite taken out revealing a creamy peanut butter center.

The implications run deeper than better recall, as studies have long proven. A 2024 review, prepared under a Defense Health Agency contract, found that, “preclinical studies and early human trials suggest that specific nutrients and diets may offer neuroprotection or benefit during mild TBI rehabilitation.” Peanut butter’s niacin is among the compounds flagged by PubMed research as exhibiting neuroprotective properties by reducing lesion volume, oxidative stress, and neuronal damage after TBI.

The brain benefits of dark chocolate have also been widely proven. So, year-round, if you’re browsing the candy aisle, try looking for dark chocolate peanut butter cups for a brain boost.  

Your Eyes Can Reveal What’s In Your Brain

In March 2026, the University of Colorado Anschutz Medical Campus published the results of a study that reveals high-speed eye-tracking technology can detect lasting neurological damage from mild traumatic brain injuries. More so, it showed that the damage that can be detected may be completely invisible to MRI scans, CT imaging, and routine clinical exams. This matters enormously. Current standard concussion assessments are largely subjective and can result in patients being told they’ve recovered when their brains are still struggling.

At the CU’s Marcus Institute for Brain Health, researchers tested 78 military veterans and measured subtle disruptions in eye movement that expose hidden neural damage. The findings were sobering: deficits persisted 10 to 15 years after the original injury. As Dr. Jeffrey Hebert, who led the study, noted, “Even when someone feels recovered, their brain may still be working differently behind the scenes.” Funded by the Department of Defense, this technology offers something conventional medicine currently cannot – objective, documented proof of brain trauma.

Man’s Best Friend Aids Brain Injury Recovery

Dogs are proving to be powerful partners in brain injury rehabilitation, offering benefits across physical, emotional, and speech therapy alike.

A March 2026 story from the University of Colorado Health (UCHealth) system documented Alan Tay, a 71-year-old stroke survivor who credits his border collie Olay with driving his recovery. Working with a neurological physical therapist, Alan used dog agility training to rebuild endurance, coordination, and memory – ultimately winning a national canine competition just three months after his stroke. Emotionally, dogs combat the depression and isolation that frequently accompany brain injury. The above-mentioned UCHealth story also notes that Olay gave Alan the will to push through. An NIH-funded clinical trial confirmed that service dogs may meaningfully reduce PTSD symptoms in military members and veterans.

Dogs can assist with speech recovery, as well. Research shows that aphasia patients produce more verbal and nonverbal communication around therapy dogs, which respond to tone and gesture rather than specific words. Speech therapy in such a uniquely low-pressure and therapeutic environment is highly beneficial for language practice.

The bipartisan SAVES Act, which reached the Senate calendar in February 2026, would fund service dogs for veterans with TBI and PTSD. Introduced by Rep. Morgan Luttrell (TX) on April 2, 2025, H.R.2605 explicitly lists “Traumatic brain injury” as a covered condition, recognizing that a trained service dog can be “optimal for the veteran to manage the disability, condition, or diagnosis and live independently.” In March 2026, America’s VetDogs launched a national campaign during this Brain Injury Awareness Month that highlights service dogs’ life-changing impact for TBI survivors, particularly as it relates to counter-balance support and deep pressure therapy.

Bacterium in Your Lungs May Be Attacking Your Brain

Chlamydia pneumoniae is a common respiratory bacterium responsible for millions of cases of pneumonia and sinus infections each year. Most people recover without incident, but a growing body of research suggests the bacterium doesn’t always leave. In a February 2026 study, published in Nature Communications, researchers at Cedars-Sinai found that Chlamydia pneumoniae can linger in the eye and brain for years, potentially aggravating Alzheimer’s disease. Scientists found that greater amounts of the bacterium were associated with more severe brain damage and worse cognitive decline, with elevated bacterial levels especially common in individuals carrying the APOE4 gene variant.

The mechanism is alarming. The bacterium can infect the olfactory and trigeminal nerves and reach the brain within 72 hours, while also dysregulating key pathways involved in Alzheimer’s disease pathogenesis.

The federal government has taken notice. The Senate Appropriations Committee’s FY 2026 spending bill proposed an increase of $100 million for Alzheimer’s disease and related dementias research at NIH National Institute on Aging. Researchers hope this increased funding hope will accelerate investigation into infection-driven neurodegeneration. What once seemed like an ordinary respiratory bug may prove to be one of the brain’s most dangerous long-term adversaries.

Cerebral Palsy: When a Damaged Brain Leaves a Lasting Mark

The brain injury comes first. Cerebral palsy follows. That distinction matters enormously, as CP is not itself a wound, but rather the permanent shadow one leaves behind.

The NIH’s National Institute of Neurological Disorders and Stroke guidance, reviewed as recently as March 13, 2026, describes CP as a disorder “caused by changes in the developing brain that disrupt its ability to control movement and maintain posture and balance.” The damage happens; CP is an outcome that the victim must live with in the future.

For most, the injury strikes before they ever draw a first breath. Oxygen deprivation during delivery, bleeding in the brain, or destruction of the delicate white matter surrounding a premature infant’s ventricles collectively account for roughly 80–90% of all cases. The CDC, in a February 2026 update, puts the scale in stark terms: about 1 in every 345 American children has CP, making it the most common childhood motor disability in the country.

Some cases, however, emerge after birth. Meningitis, near-drowning, and traumatic brain injury can all trigger CP, but only during the critical window when the brain is still forming, generally before age five. Once the skull has fully matured, the same injuries are referred to as traumatic brain injuries or acquired brain injuries.

To remedy what many see as the government’s chronic underfunding for CP, Tennessee Rep. Steve Cohen introduced H.R. 2178, Cerebral Palsy Research Program Authorization Act of 2025, on March 18, 2025. As he stated, “Cerebral palsy… is the most prevalent disability that has no designated federal funding for research.” After introduction, the bill was referred to the House Committee on Energy and Commerce. (No further action within the last Congressional session is reported.)

Cherry-Picking Superfoods to Aid TBI Recovery

A small red fruit that appears in various forms throughout the year is more than simply a tasty treat. Cherries pack natural pigment, known as anthocyanins, melatonin, and quercetin that cross the blood-brain barrier, reduce neuroinflammation, and protect injured neurons. It has long been known that anthocyanins cut brain injury volume by up to 27%, with anti-inflammatory potency similar to that of ibuprofen. Three more recent human randomized controlled trials also confirmed measurable improvements in memory, attention, and mental fatigue after daily tart cherry juice consumption.

These neurological improvements, highly beneficial to those with brain injuries, include a 23% reduction in memory errors in one 12-week. The NIH’s National Academies Press identified polyphenols found abundantly in cherries as interacting with neuronal survival pathways after traumatic brain injury (TBI). A 2025 review in Nutritional Neuroscience concluded that these compounds lessen neuroinflammation and oxidative stress following brain injury. An earlier comprehensive USDA-supported review of 29 human cherry studies also found cherry consumption decreased oxidative stress markers in 8 of 10 studies and reduced inflammation in 11 of 16 studies.

However, studies show that not all cherries deliver equal benefits. Montmorency tart cherries provide the highest benefits, though dark sweet varieties also carry high anthocyanin levels. Cherries also do not need to be eaten raw to be advantageous. Liquefied tart cherry juice concentrate has proven to be the most clinically validated form, though cherries that have been cooked retain significant amounts of active compounds. When frozen, cherries still provide these benefits, as they preserve 90–95% of polyphenols.

*Beyond delicious cherry pie, recipe research shows me that cherries are a feature in numerous recipes that are well-suited for every time of the day. For breakfast, try cherry overnight oats (rolled oats, frozen cherries, ground flaxseed, and almond butter) which requires zero morning prep and provides steady brain energy. A cherry-chocolate brain smoothie is a good snack (tart cherries blended with cocoa powder, spinach, chia seeds, and almond milk) that delivers anthocyanins and omega-3s in one glass. For TBI-related sleep disruption, tart cherry turmeric bedtime tea (cherry juice simmered with ginger, turmeric, and chamomile) supports both natural melatonin production and neuroinflammation recovery simultaneously.